Data as of Dec 06
| +0.13 / +2.17%|
The 3 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 5.00, with a high estimate of 5.50 and a low estimate of 3.25. The median estimate represents a -18.17% decrease from the last price of 6.11.
The current consensus among 3 polled investment analysts is to Hold stock in Cardiome Pharma Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.